Canopy Growth Corp (CGC) is lower by -8.30% in a Week, Should You Hold?

A rating of 72 puts Canopy Growth Corp (CGC) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. Canopy Growth Corp's score of 72 means it scores higher than 72% of stocks in the industry. Canopy Growth Corp also received an overall rating of 34, putting it above 34% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 140 out of the 148 industries.

CGC has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on CGC!

See Full CGC Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes

InvestorsObserver

’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Canopy Growth Corp Stock Today?

Canopy Growth Corp (CGC) stock has fallen -3.09% while the S&P 500 has risen 0.39% as of 2:51 PM on Tuesday, Oct 26. CGC is lower by -$0.42 from the previous closing price of $13.57 on volume of 3,503,054 shares. Over the past year the S&P 500 is up 34.79% while CGC is lower by -29.03%. CGC lost -$1.79 per share the over the last 12 months. Click Here to get the full Stock Report for Canopy Growth Corp stock.